Not all payers have readily available coverage policies and there is no consistency across payers, so reimbursement is not certain
Zeiler E, Gabriel S, Ncube M, Thompson N, Newmire D, Scharf E, et al
The safety data from animal studies is reassuring
We also have a GLP beauty program that offers Sculptra and hyperdilute Radiesse treatments at a savings for our GLP patients
Factor dose escalation into your budget from the start
In chronic kidney disease, urinary and plasma biomarkers of fibrosis, together with functional MRI approaches, represent promising tools, although further validation is required